XML 31 R11.htm IDEA: XBRL DOCUMENT v3.20.2
Revenue Recognition
 9 Months Ended
Sep. 26, 2020
Revenue from Contract with Customer [Abstract]  
Revenue Recognition REVENUE RECOGNITION

Revenue is recognized when or as a customer obtains control of promised products. The amount of revenue recognized reflects the consideration we expect to be entitled to receive in exchange for these products.

Disaggregation of Revenue

We generated net sales in the following geographic locations(1) (in millions):
 
Three Months Ended
 
Nine Months Ended
 
September 26,
2020
 
September 28,
2019
 
September 26,
2020
 
September 28,
2019
U.S.
$
820.8

 
$
785.9

 
$
2,571.1

 
$
2,323.2

Europe(2)
326.6

 
334.6

 
1,011.0

 
991.3

All other countries(3)
66.3

 
70.6

 
191.7

 
200.1

Total net sales
$
1,213.7

 
$
1,191.1

 
$
3,773.8

 
$
3,514.6


(1) Derived from the location of the entity that sells to a third party.
(2) Includes Ireland net sales of $10.8 million and $22.3 million for the three and nine months ended September 26, 2020, respectively, and $5.2 million and $17.3 million for the three and nine months ended September 28, 2019, respectively.
(3) Includes net sales generated primarily in Israel, Mexico, Australia and Canada.

Product Category

We re-aligned our product categories in our CSCA and CSCI segments as of December 31, 2019. The re-alignment standardizes our categories and product level detail to provide consistency. This transformative step will optimize the way in which management reports and evaluates our business.

    
The following is a summary of our net sales by category (in millions); the comparative periods reflect the product category re-alignment:
 
Three Months Ended
 
Nine Months Ended
 
September 26,
2020
 
September 28,
2019
 
September 26,
2020
 
September 28,
2019
CSCA(1)
 
 
 
 
 
 
 
Upper respiratory
$
114.2

 
$
123.4

 
$
385.5

 
$
377.4

Digestive health
107.1

 
85.0

 
326.1

 
293.6

Pain and sleep-aids
100.6

 
89.4

 
318.7

 
272.0

Nutrition
100.1

 
97.1

 
290.9

 
282.6

Healthy lifestyle
86.1

 
87.9

 
253.4

 
250.0

Oral self-care
81.1

 
54.2

 
199.6

 
54.2

Skincare and personal hygiene
49.2

 
45.4

 
138.8

 
136.7

Vitamins, minerals, and supplements
6.3

 
6.2

 
19.1

 
18.7

Animal health
—

 
1.8

 
—

 
43.7

Other CSCA(2)
19.3

 
22.9

 
60.1

 
48.3

Total CSCA
664.0

 
613.3

 
1,992.2

 
1,777.2

CSCI
 
 
 
 
 
 
 
Skincare and personal hygiene
83.1

 
88.9

 
275.4

 
296.5

Upper respiratory
62.3

 
72.1

 
191.9

 
193.9

Vitamins, minerals, and supplements
52.9

 
46.2

 
139.9

 
133.1

Pain and sleep-aids
49.0

 
40.5

 
136.0

 
120.3

Healthy lifestyle
40.6

 
38.2

 
124.7

 
134.2

Oral self-care
25.2

 
24.3

 
68.8

 
27.7

Digestive health
6.8

 
5.3

 
17.9

 
19.3

Other CSCI(3)
19.1

 
32.0

 
88.2

 
100.8

Total CSCI
339.0

 
347.5

 
1,042.8

 
1,025.8

RX
210.7

 
230.3

 
738.8

 
711.6

Total net sales
$
1,213.7

 
$
1,191.1

 
$
3,773.8

 
$
3,514.6


(1)    Includes net sales from our OTC contract manufacturing business.
(2)
Consists primarily of diagnostic products and other miscellaneous or otherwise uncategorized product lines and markets, none of which is greater than 10% of the segment net sales.    
(3)
Consists primarily of liquid licensed products, our distribution business and other miscellaneous or otherwise uncategorized product lines and markets, none of which is greater than 10% of the segment net sales.

While the majority of revenue is recognized at a point in time, certain of our product revenue is recognized on an over time basis. Predominately, over time customer contracts exist in contract manufacturing arrangements, which occur in both the CSCA and CSCI segments. Contract manufacturing revenue was $76.7 million and $190.7 million for the three and nine months ended September 26, 2020, respectively, and $73.9 million and $207.0 million for the three and nine months ended September 28, 2019, respectively.

We also recognize a portion of the store brand OTC product revenues in the CSCA segment on an over time basis; however, the timing difference between over time and point in time revenue recognition for store brand contracts is not significant due to the short time period between the customization of the product and shipment or delivery.

Contract Balances

The following table provides information about contract assets from contracts with customers (in millions):
 
Balance Sheet Location
 
September 26,
2020
 
December 31,
2019
Short-term contract assets
Prepaid expenses and other current assets
 
$
21.2

 
$
26.3